SIROLLI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 6.076
EU - Europa 3.309
AS - Asia 3.262
SA - Sud America 321
AF - Africa 55
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 13.046
Nazione #
US - Stati Uniti d'America 5.937
SG - Singapore 1.224
CN - Cina 964
IT - Italia 604
IE - Irlanda 485
UA - Ucraina 456
SE - Svezia 365
RU - Federazione Russa 344
TR - Turchia 335
GB - Regno Unito 315
VN - Vietnam 281
BR - Brasile 259
DE - Germania 246
FR - Francia 219
IN - India 212
FI - Finlandia 107
CA - Canada 99
HK - Hong Kong 67
BD - Bangladesh 51
NL - Olanda 32
PL - Polonia 31
JP - Giappone 26
AR - Argentina 20
BE - Belgio 20
MX - Messico 20
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
ES - Italia 18
AT - Austria 14
IQ - Iraq 13
AU - Australia 12
IR - Iran 11
EC - Ecuador 10
EG - Egitto 9
IL - Israele 8
UZ - Uzbekistan 8
ID - Indonesia 7
KR - Corea 7
LT - Lituania 7
SA - Arabia Saudita 7
EU - Europa 6
PK - Pakistan 6
PY - Paraguay 6
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
DZ - Algeria 5
JO - Giordania 5
NP - Nepal 5
BO - Bolivia 4
MA - Marocco 4
NO - Norvegia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
GT - Guatemala 3
KE - Kenya 3
MY - Malesia 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
CR - Costa Rica 2
CY - Cipro 2
DM - Dominica 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
SN - Senegal 2
SO - Somalia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GD - Grenada 1
GR - Grecia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
Totale 13.041
Città #
Singapore 847
San Jose 648
Ashburn 570
Chandler 522
Jacksonville 514
Dublin 483
Houston 334
Dallas 302
Beijing 256
Los Angeles 220
Princeton 209
Southend 206
Izmir 160
New York 160
Council Bluffs 158
Nanjing 142
Chieti 139
Dearborn 125
Santa Clara 98
Ho Chi Minh City 86
Wilmington 82
Cambridge 81
Ann Arbor 77
Nanchang 75
San Francisco 68
The Dalles 65
Altamura 64
Hong Kong 61
Tongling 60
Orem 55
Hanoi 54
Buffalo 51
Denver 46
Boardman 43
Munich 42
Atlanta 40
São Paulo 37
Woodbridge 35
Moscow 34
Hebei 32
Shenyang 32
Washington 32
Brooklyn 31
Montreal 31
Dong Ket 30
Milan 29
Kunming 27
Phoenix 27
Warsaw 26
Chicago 25
Pescara 25
Tianjin 25
London 24
Redondo Beach 23
Tokyo 23
Jiaxing 21
Boston 20
Nuremberg 19
Ottawa 19
Rome 19
Brussels 18
Changsha 18
Helsinki 18
Stockholm 18
Brno 17
Hefei 17
Jinan 17
Kocaeli 17
Amsterdam 16
Poplar 16
Chennai 15
Düsseldorf 15
Seattle 15
Toronto 15
Da Nang 13
Haiphong 13
Hangzhou 13
Johannesburg 13
Norwalk 13
Paris 12
San Mateo 12
Shanghai 12
Augusta 11
Leawood 11
Manchester 11
Naples 11
Zhengzhou 11
Ardabil 10
Bari 10
Bologna 10
Ningbo 10
Frankfurt am Main 9
Rio de Janeiro 9
Vienna 9
Cairo 8
Catania 8
Guangzhou 8
Vancouver 8
Belo Horizonte 7
Lanzhou 7
Totale 8.290
Nome #
Treatment options for anemia in kidney transplant patients: a review 1.141
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 456
Quali soluzioni future per la dialisi peritoneale? 237
Plasma protein carbonylation in chronic uremia 202
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 196
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 183
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 180
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 174
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 174
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 171
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 167
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 164
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 161
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 159
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 158
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 157
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 156
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 152
Proteomics characterization of protein adsorption onto hemodialysis membranes 151
Biocompatibility of DIAPES 149
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 148
Effect of erythropoietin on primed leucocyte expression profile. 147
Examining hemodialyzer membrane performance using proteomic technologies 144
In vitro microbiology studies on a new peritoneal dialysis connector 143
Proteomic Investigations into Hemodialysis Therapy 143
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 140
Blood cell proteomics in chronic kidney disease 139
Urinary Peptidomic Biomarkers in Kidney Diseases 139
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 137
Update sull'impiego della proteomica in emodialisi 134
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 133
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy 131
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 129
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 129
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 128
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 125
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 124
Removal of uremic plasma factors using different dialysis modalities 123
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 123
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy 122
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 121
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis 121
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 121
Use of oral hypoglycemic agents in patients with chronic kidney failure 120
Uremic toxicity and anemia 119
Proteomic analysis of protein adsorption onto haemodialysis membranes 119
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 118
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 118
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 118
Vascular inflammation in end-stage renal disease: the red blood cell connection 118
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 118
L-carnitine in uremic anemia 117
New treatment approaches for the anemia of CKD 114
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 114
Glomerulopathies associated with psoriasis: a report of three cases 114
Association of chronic microinflammation, progression of atherosclerosis and outcome in maintenance hemodialysis (HD): long term effect of dialytic membranes 113
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study 109
Approccio diagnostico al sanguinamento gastrointestinale occulto nel paizente in trattamento emodialitico 108
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations 108
Management of IgA nephropathy 107
Hypercoagulability in uraemia: role of increased surface exposure of phosphatidylserine on erythrocytes 105
L'angiodisplasia gastroenterica nel paziente uremico in trattamento emodialitico regolare. Due casi clinici 104
Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis 102
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability 102
Do haemodialysis membranes influence atherosclerosis? A one-year prospective study 101
Increased adhesion of uraemic red blood cells to vascular endothelium causes reduction of endothelial nitric oxide synthase expression 98
L’accesso vascolare negli anziani: prevenzione o spreco di risorse? 97
Utilità di uno screening urinario in età scolastica 96
null 96
Malattie renali cistiche 96
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 96
Pro-atherogenic effect of uraemic red blood cell (RBC): role of RBC surface-exposed phosphatidylserine 95
Interactions between platelets and leukocytes during hemodialysis 94
Proteomics and nephrology 94
Nefropatie glomerulari familiari ed ereditarie 94
Efficacy of hemoperfusion with Seraph-100 in series with single pass albumin dialysis in acute hepatitis B infection: A case report 93
Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes 93
Pro-inflammatory effects of erythrocytes from uremic patients on cultured human endothelial cells: insights into the signaling pathways 93
Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review 93
Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. 92
L-carnitine may decrease platelet activation response with phosphatidylserine exposure in chronic uraemia 92
Rene e paraproteine 92
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge 90
Surface Antigen Expression and Platelet Neutrophil Interactions in Haemodialysis 90
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 90
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? 90
Prognosis of CKD patients receiving outpatient nephrology care in Italy 89
Rene e Gravidanza 89
Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist 88
Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients 87
Use of Proton Pump Inhibitors Is Not Associated with Post-Dialysis Fatigue and Time of Recovery after Dialysis in Patients on Maintenance Hemodialysis 86
Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review 85
L’uremia batte…dove il dente duole!!! 81
Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia 81
null 79
Intensity, Duration, and Frequency of Post‐Dialysis Fatigue in Patients on Chronic Haemodialysis 77
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care 76
null 74
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia 72
Post-dialysis fatigue and survival in patients on chronic hemodialysis 67
Totale 13.293
Categoria #
all - tutte 51.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/2022564 35 21 9 120 31 8 21 28 51 36 47 157
2022/20231.502 139 191 87 156 133 267 89 114 222 15 50 39
2023/2024812 59 20 58 32 41 280 167 30 4 20 19 82
2024/20251.762 114 246 203 90 46 71 43 84 264 74 223 304
2025/20264.917 333 158 331 443 374 207 717 213 416 371 1.243 111
Totale 13.943